Harvard Bioscience, Inc.HBIONASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-10.5%
5Y CAGR+0.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.5%/yr
vs +2.9%/yr prior
5Y CAGR
+0.3%/yr
Recent deceleration
Acceleration
-13.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.82M | -15.2% |
| 2024 | $10.41M | -11.5% |
| 2023 | $11.76M | -4.6% |
| 2022 | $12.33M | +14.2% |
| 2021 | $10.80M | +24.3% |
| 2020 | $8.69M | -18.9% |
| 2019 | $10.71M | -2.5% |
| 2018 | $10.99M | +94.7% |
| 2017 | $5.64M | +4.7% |
| 2016 | $5.39M | - |